Cargando…

Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial

Aims: Arterial stiffness increases with both advancing age and chronic kidney disease (CKD) and may contribute to kidney function decline, but evidence is inconsistent. We hypothesized that greater baseline arterial stiffness (assessed as pulse pressure (PP) and carotid-femoral pulse-wave velocity C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowak, Kristen L., Chonchol, Michel, Jovanovich, Anna, You, Zhiying, Ambrosius, Walter T., Cho, Monique E., Glasser, Stephen, Lash, James, Simmons, Debra L., Taylor, Addison, Weiner, Daniel, Rastogi, Anjay, Oparil, Suzanne, Supiano, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814777/ https://www.ncbi.nlm.nih.gov/pubmed/32449678 http://dx.doi.org/10.5414/CN109982

Ejemplares similares

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants
por: Supiano, Mark A., et al.
Publicado: (2018)

Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Midlife and Older Adults
por: Freeberg, Kaitlin A., et al.
Publicado: (2022)

Sex Differences in Cardiovascular and All-Cause Mortality in Adults with and without CKD: NHANES 1999–2018
por: Oh, Ester S., et al.
Publicado: (2023)

Acute Kidney Injury Is Associated With an Increased Risk of Dementia
por: Kendrick, Jessica, et al.
Publicado: (2019)

Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participants
por: Nowak, Kristen L., et al.
Publicado: (2020)

Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
por: Nowak, Kristen L., et al.
Publicado: (2018)

Sex hormones and the risk of cardiovascular disease and mortality in male and female patients with chronic kidney disease: A systematic review and meta‐analysis
por: Oh, Ester S., et al.
Publicado: (2022)

Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial
por: Andrews, Emily S., et al.
Publicado: (2018)

Vitamin D Level and Risk of Community-Acquired Pneumonia and Sepsis
por: Jovanovich, Anna J., et al.
Publicado: (2014)

Incident infection following acute kidney injury with recovery to baseline creatinine: A propensity score matched analysis
por: Griffin, Benjamin R., et al.
Publicado: (2019)

25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population
por: Jovanovich, Anna J., et al.
Publicado: (2014)

APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial
por: Freedman, Barry I., et al.
Publicado: (2017)

Interleukin-1 inhibition, chronic kidney disease-mineral and bone disorder, and physical function
por: Nowak, Kristen L., et al.
Publicado: (2017)

Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease
por: Rastogi, Anjay
Publicado: (2013)

Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease
por: Rastogi, Anjay, et al.
Publicado: (2023)

Systolic Blood Pressure Trajectories and the Progression of Arterial Stiffness in Chinese Adults
por: Liu, Run, et al.
Publicado: (2022)

Leukotriene Antagonist Use is Associated With Lower Systolic Blood Pressure in Adults
por: Lai, Jennifer, et al.
Publicado: (2022)

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT
por: Beddhu, Srinivasan, et al.
Publicado: (2018)

Total cholesterol, arterial stiffness, and systolic blood pressure: a mediation analysis
por: Chen, Haojia, et al.
Publicado: (2021)

Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence
por: Covic, Adrian, et al.
Publicado: (2013)

Systolic Blood Pressure and Longitudinal Progression of Arterial Stiffness: A Quantitative Meta‐Analysis
por: Wilson, Jack, et al.
Publicado: (2020)

Mediation of Arterial Stiffness for Hyperuricemia-Related Decline of Cardiac Systolic Function in Healthy Men
por: Nakano, Hiroki, et al.
Publicado: (2021)

Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients
por: Sharma, Shailendra, et al.
Publicado: (2013)

Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease
por: Jablonski, Kristen L., et al.
Publicado: (2014)

Segmental arterial stiffness in relation to B-type natriuretic peptide with preserved systolic heart function
por: Yen, Chih-Hsuan, et al.
Publicado: (2017)

The Cardiorenal Syndrome
por: Rosner, Mitchell H., et al.
Publicado: (2011)

Cardiorespiratory synchronisation and systolic blood pressure correlation of peripheral arterial stiffness during endoscopic thoracic sympathectomy
por: Muneyasu, Toshifumi, et al.
Publicado: (2021)

Longitudinal Association of Arterial Stiffness and Pressure Wave Reflection with Decline of the Cardiac Systolic Performance in Healthy Men
por: Kumai, Kento, et al.
Publicado: (2022)

Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change
por: Aryal, Sudeep R., et al.
Publicado: (2021)

Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination
por: Pimenta, Eduardo, et al.
Publicado: (2008)

Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes
por: Pimenta, Eduardo, et al.
Publicado: (2010)

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)

Blood Pressure and the Electronic Health Record: A Work in Progress
por: Ahmad, Amier, et al.
Publicado: (2019)

Novel Medical Treatments for Hypertension and Related Comorbidities
por: Davis, Jared, et al.
Publicado: (2018)

Coffee and Arterial Hypertension
por: Surma, Stanisław, et al.
Publicado: (2021)

Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC Study
por: Frazier, Rebecca, et al.
Publicado: (2021)

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies
por: Nowak, Kristen L., et al.
Publicado: (2021)

Novel strategies for treatment of resistant hypertension
por: Judd, Eric K, et al.
Publicado: (2013)

The Principle of Stationary Action in Biophysics: Stability in Protein Folding
por: Simmons, Walter, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jag5b750alk1lkmakqp13q8hqt